Bombardieri, M., McInnes, I. B. and Pitzalis, C. (2007) Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions. Expert Opinion on Biological Therapy, 7(1), pp. 31-40. (doi: 10.1517/14712598.7.1.31) (PMID:17150017)
Full text not currently available from Enlighten.
Abstract
Interleukin-18 (IL-18), a recently identified immunoregulatory and inflammatory cytokine, has attracted a profound interest as a potential therapeutic target in autoimmune/inflammatory disorders. In this review the authors focus on: IL-18 biology as an important link between innate and adaptive immunity; evidence of its pro-inflammatory role in several human autoimmune and chronic inflammatory disorders; and data indicating that IL-18 blockade in animal models results in prevention/amelioration of the disease process and preservation of the target tissue integrity and function. Finally, the authors analyse strategies presently under development to block IL-18 function and potential pitfalls resulting from IL-18 blockade that should be considered in ongoing/future clinical trials.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | McInnes, Professor Iain |
Authors: | Bombardieri, M., McInnes, I. B., and Pitzalis, C. |
College/School: | College of Medical Veterinary and Life Sciences > School of Infection & Immunity |
Journal Name: | Expert Opinion on Biological Therapy |
Publisher: | Taylor & Francis |
ISSN: | 1471-2598 |
ISSN (Online): | 1744-7682 |
University Staff: Request a correction | Enlighten Editors: Update this record